(Q45267647)

11 December 2017

title

High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer (English)

1 reference

11 December 2017

Rumeysa Ciftci

1

1 reference

11 December 2017

Faruk Tas

2

1 reference

11 December 2017

Ceren Tilgen Yasasever

3

1 reference

11 December 2017

Ece Aksit

4

1 reference

11 December 2017

Senem Karabulut

5

1 reference

11 December 2017

Fatma Sen

6

1 reference

11 December 2017

Serkan Keskin

7

1 reference

11 December 2017

Leyla Kilic

8

1 reference

11 December 2017

Ibrahim Yildiz

9

1 reference

11 December 2017

Hamza Ugur Bozbey

10

1 reference

11 December 2017

Derya Duranyildiz

11

1 reference

11 December 2017

Sezai Vatansever

12

1 reference

11 December 2017

publication date

17 April 2014

1 reference

11 December 2017

1 reference

11 December 2017

volume

35

1 reference

11 December 2017

issue

7

1 reference

11 December 2017

page(s)

6941-6948

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-1932-y

11 December 2017

exact match

0 references

cites work

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

TGF-beta biology in mammary development and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Targeted and nontargeted effects of ionizing radiation that impact genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

The role of TGFBI in mesothelioma and breast cancer: association with tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Transgenic Mice Expressing a Dominant-Negative Mutant Type II Transforming Growth Factor-β Receptor Exhibit Impaired Mammary Development and Enhanced Mammary Tumor Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

TGF-beta 1 could be a missing link in the interplay between ER and HER-2 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Plasma transforming growth factor beta1 in breast cancer patients treated with CMF chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Circulating transforming growth factor-beta-1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1932-Y

Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer

21 January 2018

1 reference

12 December 2020

Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis

1 reference

12 December 2020

Prognostic utility of circulating transforming growth factor beta 1 in breast cancer patients

1 reference

12 December 2020

Screening of circulating TGF-β levels and its clinicopathological significance in human breast cancer

1 reference

12 December 2020

The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.

1 reference

12 December 2020

Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer

1 reference

12 December 2020

Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients

1 reference

12 December 2020

Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.

1 reference

12 December 2020

Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study

1 reference

12 December 2020

Preoperative transforming growth factor-beta 1 (TGF-beta 1) plasma levels in operable breast cancer patients.

1 reference

12 December 2020

Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression

1 reference

12 December 2020

[Expression of TGF-beta1 and the mechanism of invasiveness and metastasis induced by TGF-beta1 in breast cancer].

1 reference

12 December 2020

Serum levels of transforming growth factor beta1 in patients with breast cancer

1 reference

12 December 2020

Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer

1 reference

12 December 2020

Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast

1 reference

12 December 2020

Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel

1 reference

12 December 2020

Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor

1 reference

12 December 2020

Serum levels of angiogenic factors in early breast cancer remain close to normal

1 reference

12 December 2020

10.1007/S13277-014-1932-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1049033723

0 references

1 reference